News
Venclexta has been on the market since 2016 for CLL, initially for 17p-mutated cases, and since 2019 has been used as a first ...
AstraZeneca has proposed price cuts to its drugs in the United States, its CEO said on Tuesday, days after unveiling a $50 ...
AstraZeneca on Tuesday beat second-quarter revenue and profit expectations on robust sales of newer cancer, heart and kidney ...
AstraZeneca Tuesday beat second-quarter revenue and profit expectations on robust sales of newer cancer, heart and kidney ...
The newest BTK inhibitor on the market, Eli Lilly’s Jaypirca, has s | In a phase 3 trial, the newest Bruton’s tyrosine kinase inhibitor on the market, Eli Lilly’s Jaypirca, has shown its chops in a ...
1d
The Manila Times on MSNAstraZeneca beats profit expectations on robust drug sales, U.S. demandThe beat is a boost for the drugmaker as the wider sector braces for U.S. tariffs on pharmaceutical imports and navigates ...
1d
Zacks.com on MSNAstrazeneca (AZN) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesAlthough the revenue and EPS for Astrazeneca (AZN) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall ...
AstraZeneca PLC ( NASDAQ: AZN) Q2 2025 Earnings Conference Call July 29, 2025 9:00 AM ET ...
1d
Zacks.com on MSNAZN Q2 Earnings Meet Estimates, Sales Beat as Key Drugs OutperformAstraZeneca ’s AZN second-quarter 2025 core earnings of $1.09 per American depositary share (ADS) came in line with the Zacks ...
New data showed a survival advantage with newer chronic lymphocytic leukemia (CLL) treatments for older patients who are typically underrepresented in clinical trials.
12d
Zacks.com on MSNJ&J Expects Oncology Sales of USD 50B by 2030: Can It Achieve the Goal?JNJ eyes $50B in oncology sales by 2030, driven by drugs like Darzalex, Erleada, new launches including Carvykti and Tecvayli, and its cancer pipeline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results